IGFBP2 and central nervous system cancer: In gliomas, IGFBP2 exhibits grade-dependent expression: mRNA overexpression in glioblastoma versus normal tissues predicts poor prognosis (76), while elevated protein levels in blood/tissue positively correlate with tumor grade (77, 78).